サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：呼吸器系疾患治療薬の世界市場（2022年）
市場調査レポート
商品コード
1063055

呼吸器系疾患治療薬の世界市場（2022年）

Respiratory Diseases Drugs Global Market Report 2022
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 300 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
呼吸器系疾患治療薬の世界市場（2022年）
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 300 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の呼吸器系疾患治療薬市場について調査分析し、市場の特徴、市場の動向と戦略、市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 レポートの構造

第3章 呼吸器系疾患治療薬市場の特徴

  • 市場の定義
  • 主要セグメンテーション

第4章 呼吸器系疾患治療薬市場の製品分析

  • 主要な製品/サービス
  • 主な機能と差別化要因
  • 開発製品

第5章 呼吸器系疾患治療薬市場のサプライチェーン

  • サプライチェーン
  • 流通
  • エンドカスタマー

第6章 呼吸器系疾患治療薬市場の顧客情報

  • 顧客の好み
  • 最終用途の市場規模と成長

第7章 呼吸器系疾患治療薬市場の動向と戦略

第8章 呼吸器系疾患治療薬に対するCOVID-19の影響

第9章 呼吸器系疾患治療薬の市場規模と成長

  • 市場規模
  • 市場成長実績、金額（10億米ドル）
    • 市場促進要因
    • 市場抑制要因
  • 市場成長予測、金額（10億米ドル）
    • 市場促進要因
    • 市場抑制要因

第10章 呼吸器系疾患治療薬市場の地域分析

  • 世界の呼吸器系疾患治療薬市場、金額（10億米ドル）（2021年）：地域別
  • 世界の呼吸器系疾患治療薬市場、実績および予測（2016年～2021年）（2021年～2026年）（2031年）：地域別
  • 世界の呼吸器系疾患治療薬市場、成長および市場シェアの比較：地域別

第11章 呼吸器系疾患治療薬市場のセグメンテーション

  • 世界の呼吸器系疾患治療薬市場、実績および予測、10億米ドル（2016年～2021年）（2021年～2026年）（2031年）：タイプ別
  • 医薬品
  • 生物製剤
  • 世界の呼吸器系疾患治療薬市場、実績および予測、10億米ドル（2016年～2021年）（2021年～2026年）（2031年）：薬剤タイプ別
  • 抗喘息薬とCOPD薬
  • 鎮咳薬および風邪薬
  • 世界の呼吸器系疾患治療薬市場、実績および予測、10億米ドル（2016年～2021年）（2021年～2026年）（2031年）：流通チャネル別
  • 病院薬局
  • 小売薬局/ドラッグストア
  • その他
  • 世界の呼吸器系疾患治療薬市場、実績および予測、10億米ドル（2016年～2021年）（2021年～2026年）（2031年）：投与経路別
  • 経口
  • 非経口
  • その他
  • 世界の呼吸器系疾患治療薬市場、実績および予測、10億米ドル（2016年～2021年）（2021年～2026年）（2031年）：薬剤分類別
  • ブランド薬
  • ジェネリック薬
  • 世界の呼吸器系疾患治療薬市場、実績および予測、10億米ドル（2016年～2021年）（2021年～2026年）（2031年）：購入方法別
  • 処方薬
  • 市販薬

第12章 呼吸器系疾患治療薬市場の測定基準

  • 呼吸器系疾患治療薬の市場規模、GDPの割合、世界（2016年～2026年）
  • 一人当たりの平均呼吸器系疾患治療薬市場支出、世界（2016年～2026年）

第13章 アジア太平洋地域の呼吸器系疾患治療薬市場

第14章 西欧の呼吸器系疾患治療薬市場

第15章 東欧の呼吸器系疾患治療薬市場

第16章 北米の呼吸器系疾患治療薬市場

第17章 南米の呼吸器系疾患治療薬市場

第18章 中東の呼吸器系疾患治療薬市場

第19章 アフリカの呼吸器系疾患治療薬市場

第20章 呼吸器系疾患治療薬市場の競合情勢

  • 競合市場概要
  • 市場シェア
  • 企業プロファイル
    • Boehringer Ingelheim GmbH
    • Vertex Pharmaceuticals
    • AstraZeneca
    • Pfizer Inc.
    • GlaxosmithKline

第21章 呼吸器系疾患治療薬市場における主要な合併と買収

第22章 市場の背景：医薬品市場

  • 医薬品市場の特徴
  • 医薬品市場の実績と予測、成長、金額（10億米ドル）、世界（2016年～2021年）（2021年～2026年）（2031年）：セグメント別
  • 世界の医薬品市場、金額（10億米ドル）：地域別（2021年）
  • 世界の医薬品市場、実績および予測（2016年～2021年）（2021年～2026年）（2031年）：地域別
  • 世界の医薬品市場、金額（10億米ドル）（2016年～2021年）（2021年～2026年）（2031年）：タイプ別

第23章 推奨事項

  • 世界の呼吸器系疾患治療薬市場 - 成長国（2026年）
  • 世界の呼吸器系疾患治療薬市場 - 成長セグメント（2026年）
  • 世界の呼吸器系疾患治療薬市場 - 成長戦略（2026年）

第24章 付録

第25章 著作権と免責事項

目次
Product Code: r683

“Respiratory Diseases Drugs Global Market Report 2022” from The Business Research Company covers this critical market and the impact on it from the Covid 19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for respiratory diseases drugs which play a critical role in the treatment of patients with Covid 19.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the respiratory diseases drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Respiratory Diseases Drugs Market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider respiratory diseases drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The respiratory diseases drugs market section of the report gives context. It compares the respiratory diseases drugs market with other segments of the respiratory diseases drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, respiratory diseases drugs indicators comparison.

Scope

Markets Covered:

  • 1) By Type: Pharmaceutical Drugs; Biologics
  • 2) By Drug Type: Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
  • 4) By Route Of Administration: Oral; Parenteral; Others
  • 5) By Drug Classification: Branded Drugs; Generic Drugs
  • 6) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
  • Companies Mentioned: Boehringer Ingelheim GmbH; Vertex Pharmaceuticals; AstraZeneca; Pfizer Inc.; GlaxosmithKline
  • Metrics Covered: Number of Enterprises; Number of Employees
  • Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, respiratory diseases drugs indicators comparison.
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Respiratory Diseases Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Respiratory Diseases Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Respiratory Diseases Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Respiratory Diseases Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Respiratory Diseases Drugs Market Trends And Strategies

8. Impact Of COVID-19 On Respiratory Diseases Drugs

9. Respiratory Diseases Drugs Market Size And Growth

  • 9.1. Market Size
  • 9.2. Historic Market Growth, Value ($ Billion)
    • 9.2.1. Drivers Of The Market
    • 9.2.2. Restraints On The Market
  • 9.3. Forecast Market Growth, Value ($ Billion)
    • 9.3.1. Drivers Of The Market
    • 9.3.2. Restraints On The Market

10. Respiratory Diseases Drugs Market Regional Analysis

  • 10.1. Global Respiratory Diseases Drugs Market, 2021, By Region, Value ($ Billion)
  • 10.2. Global Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • 10.3. Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Region

11. Respiratory Diseases Drugs Market Segmentation

  • 11.1. Global Respiratory Diseases Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Pharmaceutical Drugs
  • Biologics
  • 11.2. Global Respiratory Diseases Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Anti-Asthmatics And COPD Drugs
  • Cough And Cold Preparations
  • 11.3. Global Respiratory Diseases Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
  • 11.4 Global Respiratory Diseases Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Oral
  • Parenteral
  • Others
  • 11.5. Global Respiratory Diseases Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Branded Drugs
  • Generic Drugs
  • 11.6. Global Respiratory Diseases Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs

12. Respiratory Diseases Drugs Market Metrics

  • 12.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • 12.2. Per Capita Average Respiratory Diseases Drugs Market Expenditure, 2016-2026, Global

13. Asia-Pacific Respiratory Diseases Drugs Market

  • 13.1. Asia-Pacific Respiratory Diseases Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 13.2. Asia-Pacific, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • 13.3. Asia-Pacific, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 13.4. Asia-Pacific, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 13.5. Asia-Pacific, Respiratory Diseases Drugs Market Metrics
    • 13.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Asia-Pacific Countries
    • 13.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Asia-Pacific Countries
  • 13.6. Asia-Pacific Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 13.7. Asia-Pacific Respiratory Diseases Drugs Market: Country Analysis
    • 13.7.1. China Respiratory Diseases Drugs Market
      • 13.7.1.1. China Respiratory Diseases Drugs Market Overview
      • 13.7.1.2. China Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.1.3. China Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.2. Australia Respiratory Diseases Drugs Market
      • 13.7.2.1. Australia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.2.2. Australia Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.3. Hong Kong Respiratory Diseases Drugs Market
      • 13.7.3.1. Hong Kong Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.4. India Respiratory Diseases Drugs Market
      • 13.7.4.1. India Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.4.2. India Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.5. Indonesia Respiratory Diseases Drugs Market
      • 13.7.5.1. Indonesia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.5.2. Indonesia Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.6. Japan Respiratory Diseases Drugs Market
      • 13.7.6.1. Japan Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.6.2. Japan Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.7. Malaysia Respiratory Diseases Drugs Market
      • 13.7.7.1. Malaysia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.8. New Zealand Respiratory Diseases Drugs Market
      • 13.7.8.1. New Zealand Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.9. Philippines Respiratory Diseases Drugs Market
      • 13.7.9.1. Philippines Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.10. Singapore Respiratory Diseases Drugs Market
      • 13.7.10.1. Singapore Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.11. South Korea Respiratory Diseases Drugs Market
      • 13.7.11.1. South Korea Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.11.2. South Korea Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.12. Thailand Respiratory Diseases Drugs Market
      • 13.7.12.1. Thailand Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.13. Vietnam Respiratory Diseases Drugs Market
      • 13.7.13.1. Vietnam Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14. Western Europe Respiratory Diseases Drugs Market

  • 14.1. Western Europe Respiratory Diseases Drugs Market Overview
  • 14.2. Western Europe, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • 14.3. Western Europe, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 14.4. Western Europe, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 14.5. Western Europe, Respiratory Diseases Drugs Market Metrics
    • 14.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Western Europe Countries
    • 14.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Western Europe Countries
  • 14.6. Western Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 14.7. Western Europe Respiratory Diseases Drugs Market: Country Analysis
    • 14.7.1. Austria Respiratory Diseases Drugs Market
      • 14.7.1.1. Austria Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.2. Belgium Respiratory Diseases Drugs Market
      • 14.7.2.1. Belgium Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.3. Denmark Respiratory Diseases Drugs Market
      • 14.7.3.1. Denmark Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.4. Finland Respiratory Diseases Drugs Market
      • 14.7.4.1. Finland Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.5. France Respiratory Diseases Drugs Market
      • 14.7.5.1. France Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.5.2. France Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.6. Germany Respiratory Diseases Drugs Market
      • 14.7.6.1. Germany Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.6.2. Germany Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.7. Ireland Respiratory Diseases Drugs Market
      • 14.7.7.1. Ireland Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.8. Italy Respiratory Diseases Drugs Market
      • 14.7.8.1. Italy Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.9. Netherlands Respiratory Diseases Drugs Market
      • 14.7.9.1. Netherlands Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.10. Norway Respiratory Diseases Drugs Market
      • 14.7.10.1. Norway Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.11. Portugal Respiratory Diseases Drugs Market
      • 14.7.11.1. Portugal Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.12. Spain Respiratory Diseases Drugs Market
      • 14.7.12.1. Spain Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.13. Sweden Respiratory Diseases Drugs Market
      • 14.7.13.1. Sweden Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.14. Switzerland Respiratory Diseases Drugs Market
      • 14.7.14.1. Switzerland Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.15. UK Respiratory Diseases Drugs Market
      • 14.7.15.1. UK Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.15.2. UK Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15. Eastern Europe Respiratory Diseases Drugs Market

  • 15.1. Eastern Europe Respiratory Diseases Drugs Market Overview
  • 15.2. Eastern Europe, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • 15.3. Eastern Europe, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 15.4. Eastern Europe, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 15.5. Eastern Europe, Respiratory Diseases Drugs Market Metrics
    • 15.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Eastern Europe Countries
    • 15.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Eastern Europe Countries
  • 15.6. Eastern Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 15.7. Eastern Europe Respiratory Diseases Drugs Market: Country Analysis
    • 15.7.1. Czech Republic Respiratory Diseases Drugs Market,
      • 15.7.1.1. Czech Republic Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.2. Poland Respiratory Diseases Drugs Market
      • 15.7.2.1. Poland Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.3. Romania Respiratory Diseases Drugs Market
      • 15.7.3.1. Romania Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.4. Russia Respiratory Diseases Drugs Market
      • 15.7.4.1. Russia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 15.7.4.2. Russia Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16. North America Respiratory Diseases Drugs Market

  • 16.1. North America Respiratory Diseases Drugs Market Overview
  • 16.2. North America, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • 16.3. North America, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 16.4. North America, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 16.5. North America, Respiratory Diseases Drugs Market Metrics
    • 16.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, North America Countries
    • 16.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, North America Countries
  • 16.6. North America Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 16.7. North America Respiratory Diseases Drugs Market: Country Analysis
    • 16.7.1. Canada Respiratory Diseases Drugs Market
      • 16.7.1.1. Canada Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 16.7.2. Mexico Respiratory Diseases Drugs Market
      • 16.7.2.1. Mexico Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 16.7.3. USA Respiratory Diseases Drugs Market
      • 16.7.3.1. USA Respiratory Diseases Drugs Market Overview
      • 16.7.3.2. USA Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 16.7.3.3. USA Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17. South America Respiratory Diseases Drugs Market

  • 17.1. South America Respiratory Diseases Drugs Market Overview
  • 17.2. South America, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • 17.3. South America, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 17.4. South America, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 17.5. South America, Respiratory Diseases Drugs Market Metrics
    • 17.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, South America Countries
    • 17.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, South America Countries
  • 17.6. South America Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 17.7. South America Respiratory Diseases Drugs Market: Country Analysis
    • 17.7.1. Argentina Respiratory Diseases Drugs Market
      • 17.7.1.1. Argentina Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.2. Brazil Respiratory Diseases Drugs Market
      • 17.7.1.1. Brazil Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 17.7.2.2. Brazil Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.3. Chile Respiratory Diseases Drugs Market
      • 17.7.3.1. Chile Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.4. Colombia Respiratory Diseases Drugs Market
      • 17.7.4.1. Colombia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.5. Peru Respiratory Diseases Drugs Market
      • 17.7.5.1. Peru Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.6. Venezuela Respiratory Diseases Drugs Market
      • 17.7.6.1. Venezuela Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18. Middle East Respiratory Diseases Drugs Market

  • 18.1. Middle East Respiratory Diseases Drugs Market Overview
  • 18.2. Middle East, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • 18.3. Middle East, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 18.4. Middle East, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 18.5. Middle East, Respiratory Diseases Drugs Market Metrics
    • 18.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Middle East Countries
    • 18.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Middle East Countries
  • 18.6. Middle East Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 18.7. Middle East Respiratory Diseases Drugs Market: Country Analysis
    • 18.7.1. Saudi Arabia Respiratory Diseases Drugs Market
      • 18.7.1.1. Saudi Arabia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.2. Israel Respiratory Diseases Drugs Market
      • 18.7.2.1. Israel Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.3. Turkey Respiratory Diseases Drugs Market
      • 18.7.3.1. Turkey Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.4. UAE Respiratory Diseases Drugs Market
      • 18.7.4.1. UAE Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19. Africa Respiratory Diseases Drugs Market

  • 19.1. Africa Respiratory Diseases Drugs Market Overview
  • 19.2. Africa, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • 19.3. Africa, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 19.4. Africa, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 19.5. Africa, Respiratory Diseases Drugs Market Metrics
    • 19.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Africa Countries
    • 19.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Africa Countries
  • 19.6. Africa Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 19.7. Africa Respiratory Diseases Drugs Market: Country Analysis
    • 19.7.1. Egypt Respiratory Diseases Drugs Market
      • 19.7.1.1. Egypt Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 19.7.2. Nigeria Respiratory Diseases Drugs Market
      • 19.7.2.1. Nigeria Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 19.7.3. South Africa Respiratory Diseases Drugs Market
      • 19.7.3.1. South Africa Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

20. Respiratory Diseases Drugs Market Competitive Landscape

  • 20.1. Competitive Market Overview
  • 20.2. Market Shares
  • 20.3. Company Profiles
    • 20.3.1. Boehringer Ingelheim GmbH
      • 20.3.1.1. Company Overview
      • 20.3.1.2. Products And Services
      • 20.3.1.3. Strategy
      • 20.3.1.4. Financial Performance
    • 20.3.2. Vertex Pharmaceuticals
      • 20.3.2.1. Company Overview
      • 20.3.2.2. Products And Services
      • 20.3.2.3. Strategy
      • 20.3.2.4. Financial Performance
    • 20.3.3. AstraZeneca
      • 20.3.3.1. Company Overview
      • 20.3.3.2. Products And Services
      • 20.3.3.3. Strategy
      • 20.3.3.4. Financial Performance
    • 20.3.4. Pfizer Inc.
      • 20.3.4.1. Company Overview
      • 20.3.4.2. Products And Services
      • 20.3.4.3. Strategy
      • 20.3.4.4. Financial Performance
    • 20.3.5. GlaxosmithKline
      • 20.3.5.1. Company Overview
      • 20.3.5.2. Products And Services
      • 20.3.5.3. Strategy
      • 20.3.5.4. Financial Performance

21. Key Mergers And Acquisitions In The Respiratory Diseases Drugs Market

22. Market Background: Pharmaceutical Drugs Market

  • 22.1. Pharmaceutical Drugs Market Characteristics
  • 22.2. Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F Growth, By Segment, Value ($ Billion), Global
  • 22.3. Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • 22.4. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • 22.5. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

23. Recommendations

  • 23.1. Global Respiratory Diseases Drugs Market In 2026- Growth Countries
  • 23.2. Global Respiratory Diseases Drugs Market In 2026- Growth Segments
  • 23.3. Global Respiratory Diseases Drugs Market In 2026- Growth Strategies

24. Appendix

  • 24.1. NAICS Definitions Of Industry Covered In This Report
  • 24.2. Abbreviations
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company

25. Copyright And Disclaimer